Stuart Chaussee & Associates, Inc. - Novo Nordisk A/S ADR ownership

Novo Nordisk A/S ADR's ticker is and the CUSIP is K7314N152. A total of 1 filers reported holding Novo Nordisk A/S ADR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Stuart Chaussee & Associates, Inc. ownership history of Novo Nordisk A/S ADR
ValueSharesWeighting
Q1 2023$34,056
+17.6%
2140.0%0.01%
+9.1%
Q4 2022$28,963
+37.9%
2140.0%0.01%
-77.6%
Q3 2022$21,000
-12.5%
2140.0%0.05%
-5.8%
Q2 2022$24,000
+700.0%
214
+463.2%
0.05%
+5100.0%
Q1 2021$3,000380.00%
Other shareholders
Novo Nordisk A/S ADR shareholders Q4 2022
NameSharesValueWeighting ↓
Stuart Chaussee & Associates, Inc. 214$28,9630.01%
View complete list of Novo Nordisk A/S ADR shareholders